| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75673865a820b7380364ac492db9fd34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate |
2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa566462198defb94338a4de0b1b292d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9756caf9f3dd368fe82ff8bae55f09ae |
| publicationDate |
2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1852435-A1 |
| titleOfInvention |
A process for the manufacture of famciclovir using phase-transfer catalysts |
| abstract |
The invention relates to a process for the preparation of Famciclovir, which comprises the preparation of a compound of formula (II)n nwherein X is a halogen atom nby reaction of a compound of formula (III)n nwith a compound of formula (VII)n nwherein L is a leaving group, in the presence of a catalytic amount of a quaternary ammonium salt, nfollowed by hydrogenation of compound (II) to Famciclovir. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101555249-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104193801-A |
| priorityDate |
2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |